Past and recent medical history, comorbidities, presumed VPA ingested doses, co-ingested compounds, clinical presentation, laboratory parameters, toxicological analysis, management, complications and outcome were recorded
2 These studies, including the SUSTAIN clinical trial program, demonstrated both safety and effectiveness for treating type 2 diabetes
Human duodenal enteroendocrine cells: Source of both incretin peptides, GLP-1 and GIP
PMID 9851930
Policy Nonmelanoma skin cancers are types of skin cancer that form in the top layer of your skin
in contrast, the 4 mg dose of efpeglenatide had no statistically significant effect on HF hospitalisation